Disclosures for "Linezolid As An Add On Treatment In The Intensive Phase Of Tubercular Meningitis. A Randomized Controlled Pilot Trial. ")
-
Dr. Sahib has nothing to disclose.
-
Dr. Bhatia has nothing to disclose.
-
M.V. Padma Srivastava has nothing to disclose.
-
Mamta Singh Bhushan has nothing to disclose.
-
Vishnu VY has nothing to disclose.
-
Roopa Rajan has received research support from DBT. Roopa Rajan has received research support from DST-SERB. The institution of Roopa Rajan has received research support from Michael J Fox Foundaton.
-
The institution of Anu Gupta has received research support from ICMR.
-
Dr. Srivastava has nothing to disclose.